Get the Stockscreener App
98.97
1.76%
-1.77
Pre-market:
99.75
0.78
+0.79%
Zimmer Biomet Holdings Inc stock is traded at $98.97, with a volume of 1.31M.
It is down -1.76% in the last 24 hours and up +10.31% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$100.74
Open:
$100.01
24h Volume:
1.31M
Relative Volume:
0.57
Market Cap:
$18.88B
Revenue:
$8.41B
Net Income/Loss:
$760.80M
P/E Ratio:
25.70
EPS:
3.8513
Net Cash Flow:
$1.05B
1W Performance:
-0.60%
1M Performance:
+10.31%
6M Performance:
+0.22%
1Y Performance:
-6.38%
1-Day Range:
$98.97
$101.63
1-Week Range:
$97.87
$101.95
52-Week Range:
$79.12
$108.29
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
98.97 | 19.21B | 8.41B | 760.80M | 1.05B | 3.8513 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-23-26 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-20-26 | Initiated | William Blair | Mkt Perform |
| Jan-09-26 | Downgrade | Goldman | Neutral → Sell |
| Jan-06-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-16-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jul-15-25 | Upgrade | Roth Capital | Neutral → Buy |
| Dec-17-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
923,552 Shares in Zimmer Biomet Holdings, Inc. $ZBH Acquired by Deutsche Bank AG - MarketBeat
BlackRock Inc. Makes New $1.34 Billion Investment in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
ZBH5302814 Bond Profile — Key Metrics - TradingView
Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Is Zimmer Biomet Stock Worth Retaining in Your Portfolio Now? - Yahoo Finance Singapore
United Bank Invests $1.26 Million in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
482,055 Shares in Zimmer Biomet Holdings, Inc. $ZBH Acquired by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
DCF Advisers LLC Purchases Shares of 30,500 Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet (ZBH) Stock Still Looks Discounted After a 28% Five Year Slide - Yahoo Finance
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet stock holds gains after a solid Q2 beat - Ad-hoc-news.de
1,681,360 Shares in Zimmer Biomet Holdings, Inc. $ZBH Purchased by Equity Investment Corp - MarketBeat
First National Bank of Omaha Invests $12.55 Million in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Capital International Investors Expands Zimmer Biomet Holdings I - GuruFocus
Zimmer Biomet stock edges higher as investors weigh Q2 trend and fresh institutional buying - AD HOC NEWS
Grandfield & Dodd LLC Buys New Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
J.P. Morgan Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Raises Target Price to $117 - Moomoo
Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Zimmer Biomet stock edges lower as investors weigh Q2 2026 cash flow and $1 billion buyback plan - AD HOC NEWS
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 6.88% Potential Upside in the Medical Device Sector - DirectorsTalk Interviews
297,894 Shares in Zimmer Biomet Holdings, Inc. $ZBH Bought by Alberta Investment Management Corp - MarketBeat
Zimmer Biomet Holdings (ZBH) Could Be 2% Undervalued As Q2 Beat Lifts The Story - Sahm
Everett Harris & Co. CA Invests $2.55 Million in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Chintan Desai Net Worth (2026) - GuruFocus
Will Zimmer Biomet’s Upgraded 2026 Guidance and Buyback Shift Zimmer Biomet Holdings’ (ZBH) Narrative - Sahm
SYK Stock Gains 3.8% Since March-End: What's Driving the Uptrend? - TradingView
Are Wall Street Analysts Bullish on Zimmer Biomet Stock? - Barchart.com
5 Revealing Analyst Questions From Zimmer Biomet’s Q2 Earnings Call - Yahoo Finance
Handelsbanken Fonder AB Buys 28,130 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet (ZBH) sees Dodge & Cox disclose 12.5% ownership stake - Stock Titan
Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next? - TradingView
Citi Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $99 - Moomoo
Zimmer Biomet reports strong second quarter financial results - Today's Medical Developments
Donald TrumpZIMMER BIOMET HOLDINGS INC Trump Trade on May. 11, 2026 - Quiver Quantitative
Zimmer Biomet (ZBH): Capital International Investors reports 6.4% ownership stake - Stock Titan
Assenagon Asset Management S.A. Buys 97,887 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet (NYSE:ZBH) Price Target Raised to $100.00 - MarketBeat
Price to earnings forward of Zimmer Biomet Holdings, Inc. – NYSE:ZBH - TradingView
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Strong Potential Upside with Robust Analyst Ratings - DirectorsTalk Interviews
Zimmer Biomet Q2 Earnings Call Highlights - MarketBeat
Zimmer Biomet Holdings, Inc. (ZBH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Q2 2026 Zimmer Biomet Holdings, Inc Earnings Call Transcript - GuruFocus
Wall Street Zen Downgrades Zimmer Biomet (NYSE:ZBH) to Hold - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Zimmer Biomet - The National Law Review
Wells Fargo Adjusts Price Target on Zimmer Biomet to $103 From $90 - Moomoo
Wilsey Asset Management Inc. Has $36.32 Million Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Truist Adjusts Price Target on Zimmer Biomet to $106 From $92, Maintains Hold Rating - marketscreener.com
Zimmer Biomet Holdings (ZBH) Following Its Beat And Guidance Lift, Is The Valuation Catching Up? - finance.yahoo.com
Zimmer Biomet (ZBH) Stock Gets Fair Value Bump After Mixed Analyst Views - Yahoo Finance
Zimmer Biomet Holdings, Inc. (ZBH) Stock forecasts - Yahoo Finance Singapore
Baird Adjusts Zimmer Biomet Price Target to $104 From $92 - Moomoo
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
0.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):